Chronic progressive external ophthalmoplegia plus
Article Sidebar
Views | PDF/EPUB Downloads:
7
/ 7
/ 4
Main Article Content
Abstract
Chronic progressive external ophthalmoplegia (CPEO) is an uncommon mitochondrial myopathy that advances gradually, characterized by ophthalmoplegia and ptosis. CPEO can emerge as an isolated condition or as part of a syndrome involving additional neurological impairments, termed CPEO plus (CPEO+). CPEO+ requires comprehensive evaluation, where a multidisciplinary approach, encompassing neurological assessments of both central and peripheral systems, along with examinations of musculoskeletal and cardiac functions is recommended. Essential diagnostic tools include muscle biopsy, biochemical analysis of muscles, neuroradiological or orbital computed tomography/magnetic resonance imaging evaluation, and molecular genetic testing. Due to the scarcity of diagnostic facilities in sub‑Saharan Africa, including Tanzania, diagnosis of CPEO+ is delayed leading to patient suffering, however, its management remains intricate and noncurative. This article presents a rare case study of a 23‑year‑old male. He exhibits clinical, histological, and radiological characteristics consistent with CPEO+.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
1. Engelsen BA, Tzoulis C, Karlsen B, Lillebø A, Laegreid LM, Aasly J, et al. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain 2008;131:818‑28.
2. Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, et al. Melas: An original case and clinical criteria for diagnosis. Neuromuscul Disord 1992;2:125‑35.
3. Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 2001;49:377‑83.
4. Kaur A, Mathur K, Harsh A, Thakar K. Progressive external ophthalmoplegia – A case report. Indian J Pathol Microbiol 2023;66:883‑5.
5. Holt IJ, Harding AE, Cooper JM, Schapira AH, Toscano A, Clark JB, et al. Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989;26:699‑708.
6. Yu‑Wai‑Man C, Smith FE, Firbank MJ, Guthrie G, Guthrie S, Gorman GS, et al. Extraocular muscle atrophy and central nervous system involvement in chronic progressive external ophthalmoplegia. PLoS One 2013;8:e75048.
7. Orsucci D, Caldarazzo Ienco E, Rossi A, Siciliano G, Mancuso M. Mitochondrial syndromes revisited. J Clin Med 2021;10:1249.
8. Deschauer M. Mitochondrial Encephalomyopathies. Psychoneuro 2003;29:108‑12.
9. Ali A, Esmaeil A, Behbehani R. Mitochondrial chronic progressive external ophthalmoplegia. Brain Sci 2024;14:135.
10. Ortube MC, Bhola R, Demer JL. Orbital magnetic resonance imaging of extraocular muscles in chronic progressive external ophthalmoplegia: Specific diagnostic findings. J AAPOS 2006;10:414‑8.
11. Pitceathly RD, Morrow JM, Sinclair CD, Woodward C, Sweeney MG, Rahman S, et al. Extra‑ocular muscle MRI in genetically‑defined mitochondrial disease. Eur Radiol 2016;26:130‑7.
12. DiMauroS, BonillaE, De VivoDC. Does the patient have a mitochondrial encephalomyopathy? J Child Neurol 1999;14 Suppl 1:S23‑35.
13. Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: Analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993;14:1119‑37.
14. Laforêt P, Lombès A, Eymard B, Danan C, Chevallay M, Rouche A,et al. Chronic progressive external ophthalmoplegia with ragged‑red fibers: Clinical, morphological and genetic investigations in 43 patients. Neuromuscul Disord 1995;5:399‑413.
15. LouHC, Reske‑NielsenE. Letter: Progressive external ophthalmoplegia: Evidence for a disorder in pyruvate‑lactate metabolism. Arch Neurol 1976;33:455‑6